MST1 and diabetes mellitus: Metformin has shown beneficial effects in the management of T2D as a widely used first-line treatment for diabetes mellitus, so we next investigated whether IHMT-MST1-39 has synergistic anti-diabetic effect in combination with metformin in vivo.